Home › Companies › Haemonetics Corporation › 2025-2026

Haemonetics Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Haemonetics Corporation’s Form 8-K, filed July 25, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.

  • 11Ballot items
  • 341Asset managers
  • 4,168Fund votes
  • July 24, 2025Meeting date

Results at a glance

Meeting of July 24, 2025: 11 items on Haemonetics Corporation’s Form 8-K, filed July 25, 2025: 2 approved · 9 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Haemonetics Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Haemonetics Corporation

These tallies are Haemonetics Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 25, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Haemonetics Corporation — official shareholder meeting results, meeting held July 24, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Christopher A. Simon 43,756,151---- 99,1661,757,724 99.7%Not verified—
Elect Director: Robert E. Abernathy 43,061,317---- 794,0001,757,724 98%Not verified—
Elect Director: Diane M. Bryant 43,568,258---- 287,0591,757,724 99.3%Not verified—
Elect Director: Michael J. Coyle 43,670,835---- 184,4821,757,724 99.5%Not verified—
Elect Director: Charles J. Dockendorff 42,588,774---- 1,266,5431,757,724 97%Not verified—
Elect Director: Lloyd E. Johnson 43,151,041---- 704,2761,757,724 98%Not verified—
Elect Director: Mark W. Kroll 42,739,455---- 1,115,8621,757,724 97%Not verified—
Elect Director: Claire Pomeroy 43,567,795---- 287,5221,757,724 99.3%Not verified—
Elect Director: Ellen M. Zane 43,066,065---- 789,2521,757,724 98%Not verified—
2. The compensation of the Company's named executive officers based upon the following votes 43,016,961585,626252,730 --1,757,724 99%Approved—
3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 28, 2026 based upon the following votes 43,843,3961,525,114244,531 ---- 97%Approved—

Source: Haemonetics Corporation, Form 8-K, filed with the SEC on July 25, 2025 — read the filing on EDGAR.

How asset managers voted at the Haemonetics Corporation 2025-2026 meeting

Each item below shows how the 341 asset managers that disclosed a Haemonetics Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Charles J. Dockendorff

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 42,588,774WITHHELD: 1,266,543
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Charles J. Dockendorff

Haemonetics Corporation’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 42,588,774 for, 1,266,543 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 24,966,330 for, 140,012 withheld.

FOR
FOR: 24,966,330WITHHOLD: 140,012
Largest asset managers voting on “Election of Directors: Charles J. Dockendorff” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9300 030For
Bridge Builder Trust158,8710 0101,766Mixed
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

2. Elect Director: Christopher A. Simon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 43,756,151WITHHELD: 99,166
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Christopher A. Simon

Haemonetics Corporation’s own tally for this item (“Elect Director: Christopher A. Simon”): 43,756,151 for, 99,166 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,092,396 for, 13,946 withheld.

FOR
FOR: 25,092,396WITHHOLD: 13,946
Largest asset managers voting on “Election of Directors: Christopher A. Simon” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

3. Elect Director: Claire Pomeroy

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 43,567,795WITHHELD: 287,522
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Claire Pomeroy

Haemonetics Corporation’s own tally for this item (“Elect Director: Claire Pomeroy”): 43,567,795 for, 287,522 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,083,474 for, 22,868 withheld.

FOR
FOR: 25,083,474WITHHOLD: 22,868
Largest asset managers voting on “Election of Directors: Claire Pomeroy” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

4. Elect Director: Diane M. Bryant

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 43,568,258WITHHELD: 287,059
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Diane M. Bryant

Haemonetics Corporation’s own tally for this item (“Elect Director: Diane M. Bryant”): 43,568,258 for, 287,059 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,083,474 for, 22,868 withheld.

FOR
FOR: 25,083,474WITHHOLD: 22,868
Largest asset managers voting on “Election of Directors: Diane M. Bryant” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

5. Elect Director: Ellen M. Zane

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 43,066,065WITHHELD: 789,252
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Ellen M. Zane

Haemonetics Corporation’s own tally for this item (“Elect Director: Ellen M. Zane”): 43,066,065 for, 789,252 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,066,527 for, 39,815 withheld.

FOR
FOR: 25,066,527WITHHOLD: 39,815
Largest asset managers voting on “Election of Directors: Ellen M. Zane” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,4910 0423For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

6. Elect Director: Lloyd E. Johnson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 43,151,041WITHHELD: 704,276
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Lloyd E. Johnson

Haemonetics Corporation’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 43,151,041 for, 704,276 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,074,947 for, 31,395 withheld.

FOR
FOR: 25,074,947WITHHOLD: 31,395
Largest asset managers voting on “Election of Directors: Lloyd E. Johnson” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

7. Elect Director: Mark W. Kroll

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 42,739,455WITHHELD: 1,115,862
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Mark W. Kroll

Haemonetics Corporation’s own tally for this item (“Elect Director: Mark W. Kroll”): 42,739,455 for, 1,115,862 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 24,981,244 for, 125,098 withheld.

FOR
FOR: 24,981,244WITHHOLD: 125,098
Largest asset managers voting on “Election of Directors: Mark W. Kroll” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9300 030For
Bridge Builder Trust158,8710 0101,766Mixed
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

8. Elect Director: Michael J. Coyle

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 43,670,835WITHHELD: 184,482
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Michael J. Coyle

Haemonetics Corporation’s own tally for this item (“Elect Director: Michael J. Coyle”): 43,670,835 for, 184,482 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,092,396 for, 13,946 withheld.

FOR
FOR: 25,092,396WITHHOLD: 13,946
Largest asset managers voting on “Election of Directors: Michael J. Coyle” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

9. Elect Director: Robert E. Abernathy

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 43,061,317WITHHELD: 794,000
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Directors: Robert E. Abernathy

Haemonetics Corporation’s own tally for this item (“Elect Director: Robert E. Abernathy”): 43,061,317 for, 794,000 withheld, per its Form 8-K filed July 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,068,560 for, 37,782 withheld.

FOR
FOR: 25,068,560WITHHOLD: 37,782
Largest asset managers voting on “Election of Directors: Robert E. Abernathy” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 013,946For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

10. 2. The compensation of the Company's named executive officers based upon the following votes

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 43,016,961AGAINST: 585,626
Details: description as filed, official tally, votes by 335 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.

Haemonetics Corporation’s own tally for this item (“2. The compensation of the Company's named executive officers based upon the following votes”): 43,016,961 for, 585,626 against — passed, per its Form 8-K filed July 25, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 102 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,488426 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,421539 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
RBB FUND, INC.53,071103,852 00Mixed
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For

Fund voting reports, all 102 managers: 25,061,187 for, 135,061 against, 13,946 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 262 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Neuberger Berman4,151,157700 00For
T. Rowe Price2,285,5930 00For
BlackRock1,973,031209 00For
State Street1,694,863539 00For
Wellington1,685,1140 00For
River Road Asset Management, LLC1,360,8300 00For
GEODE CAPITAL MANAGEMENT, LLC1,235,7650 00For
Capital Research Global Investors1,139,0430 00For
Allspring987,4570 00For
Fidelity819,2210 00For
FRANKLIN ADVISERS INC581,3340 00For
SILVERCREST ASSET MANAGEMENT GROUP LLC548,45716,570 00For
Charles Schwab557,0580 00For
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/462,5670 00For
John Hancock449,1940 00For
Boston Partners432,4110 00For
BOSTON TRUST WALDEN NATIONAL ASSOCIATION431,7270 00For
Fisher Asset Management, LLC422,9450 00For
Northern Trust379,9930 00For
Aristotle Capital Boston, LLC351,9490 00For
MELLON INVESTMENTS Corp321,6660 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC306,2660 00For
LONDON CO OF VIRGINIA286,4880 00For
Vanguard248,8800 00For
MARSHALL WACE, LLP243,3370 00For

Institutional-manager reports, all 262 managers: 27,372,646 for, 353,574 against, 225,158 abstained, 435 not voted. Showing the 25 largest; see all in the interactive database.

11. 3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 43,843,396AGAINST: 1,525,114
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: To Ratify The Appointment Of Ernst & Young Llp As Our Independent Registered Public Accounting Firm For The Fiscal Year Ending March 28, 2026.

Haemonetics Corporation’s own tally for this item (“3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 28, 2026 based upon the following votes”): 43,843,396 for, 1,525,114 against — passed, per its Form 8-K filed July 25, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 28, 2026 based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,083,021 for, 9,375 against, 13,946 abstained.

FOR
FOR: 25,083,021AGAINST: 9,375ABSTAIN: 13,946
Largest asset managers voting on “To Ratify The Appointment Of Ernst & Young Llp As Our Independent Registered Public Accounting Firm For The Fi” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,491423 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,93030 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

Largest Haemonetics Corporation shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 51,152,886 shares outstanding at the time of that meeting.

Fund voting reports: top Haemonetics Corporation shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 12.08%
2BlackRock 6.85%
3Neuberger Berman 4.84%
4Fidelity 3.82%
5Capital Group 2.23%
6Royce 1.86%
7T. Rowe Price 1.68%
8Allspring 1.51%
9Charles Schwab 1.09%
10FRANKLIN STRATEGIC SERIES 1.03%
Institutional-manager reports: top Haemonetics Corporation shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Neuberger Berman 8.12%
2T. Rowe Price 4.47%
3BlackRock 3.86%
4State Street 3.31%
5Wellington 3.29%
6River Road Asset Management, LLC 2.66%
7GEODE CAPITAL MANAGEMENT, LLC 2.42%
8Capital Research Global Investors 2.23%
9Allspring 1.93%
10Fidelity 1.60%

Reported Haemonetics Corporation holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Haemonetics Corporation holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 10.99% 13F
Neuberger Berman Group LLC 6.90% DEF14A
AQR Capital Management LLC 6.18% DEF14A
Vanguard Portfolio Management LLC 5.08% DEF14A
Vanguard Capital Management 4.78% 13G
State Street 3.47% 13F
Dimensional Fund Advisors 2.59% 13F
FMR (Fidelity) 2.49% 13F
Geode Capital 2.38% 13F
Goldman Sachs 1.89% 13F

Percentages above are of 51,152,886 shares outstanding, as reported by Haemonetics Corporation on its Form 10-Q dated June 29, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Haemonetics Corporation’s 10-Q dated June 29, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At Haemonetics Corporation's shareholder meeting held July 24, 2025, in the 2025-2026 proxy season, 341 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 4,168 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — Haemonetics Corporation's filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Haemonetics Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 25, 2025.

Haemonetics Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.